Back to search
Comparable activity with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin (PE) as treatment for chemotherapy-naïve patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Final results of a randomized phase III trial (389)
Data up to Jan 2025
Published2005
Citations14
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...